Luceco logo

LUCE - Luceco News Story

345p -4.0  -1.1%

Last Trade - 14/05/21

Sector
Industrials
Size
Mid Cap
Market Cap £554.8m
Enterprise Value £573.1m
Revenue £176.2m
Position in Universe 588th / 1826

Luceco PLC - Employee Benefit Trust Share Purchase

Fri 25th January, 2019 5:04pm
RNS Number : 1938O
Luceco PLC
25 January 2019
 

LUCECO PLC (THE "COMPANY")

 

Luceco plc confirms that on 18 January 2019 Link Trustees (Jersey) Limited, acting as trustee of the Luceco plc Employee Benefit Trust (the 'EBT'), purchased in the market a total of 250,000 Ordinary shares of nominal value 0.05 pence each in the capital of the Company at a price of £0.417 per share.

On 25 January 2019, Link Trustees (Jersey) Limited purchased in the market an additional 88,130 Ordinary shares of nominal value 0.05 pence each in the capital of the Company at a price of £0.45 per share.

Immediately following the above transaction, the EBT held 1,892,130 Ordinary shares, representing 1.176% of the Company's issued share capital with voting rights. All Shares held by the EBT will ultimately be used to satisfy share awards and options granted under the Company's various share incentive arrangements. 

The Executive Directors and Persons Discharging Managerial Responsibility ("PDMR's") of the Company, together with other employees, are included in the potential beneficiaries of the EBT and are therefore treated as having an interest in some of those shares and the dealings thereof.

The Company's issued ordinary share capital consists of 160,800,000 Ordinary shares of 0.05 pence each.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGMGZMNKMGLZM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.